Skip to main content
SpringerLink
Log in

High frequency of lipoprotein risk levels for cardiovascular disease in Takayasu arteritis

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The objective of this study is to characterize the lipoprotein risk levels in Takayasu arteritis (TA) patients and its possible association with disease activity and glucocorticoid use. Twenty-five female TA patients were consecutively included and compared with 30 age-, gender-, and body mass index-matched healthy controls. Demographic features and the lipid profile were determined and cardiovascular risk levels were evaluated according to NCEP/ATPIII. Total cholesterol (TC), LDL-c, HDL-c, and triglycerides were determined after a 12-h overnight fast. Exclusion criteria were conditions that interfere in the lipid profile. The disease duration was 6.6 ± 7.4 years; 30% had clinical activity and 80% had laboratory activity. Regarding NCEP/ATPIII risk levels, TA patients presented higher frequency of lipid risk compared to controls: high TC (48% vs. 20%, p = 0.04), low HDL-c (20% vs. 0%, p = 0.015), and high triglycerides (36% vs. 10%, p = 0.026). No difference was observed related to LDL-c risk levels between both groups (40% vs. 20%, p = 0.14). Remarkably, 60% of the patients had at least one lipid risk factor for cardiovascular disease. No difference in the lipids was observed between patients with and without clinical activity; however, those with laboratory activity showed lower levels of HDL-c (1.37 ± 0.42 vs. 2.00 ± 0.63 mmol/L, p = 0.012) than patients without this activity. A negative correlation was found between HDL-c and CRP levels (r = −0.42, p = 0.04). Lipids were similar in patients under glucocorticoid compared to those without this therapy. This is the first study to identify that TA, an inflammatory disease, has a proatherogenic lipid profile which is associated to laboratory disease activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Yamato M, Lecky JW, Hiramatsu K, Kohda E (1986) Takayasu arteritis: radiographic and angiographic findings in 59 patients. Radiology 161:329–334

    PubMed  CAS  Google Scholar 

  2. Numano F (2002) Takayasu's arteritis: clinical aspects. In: Hoffman GS, Weyand CM (eds) Inflammatory diseases of blood vessels. Marcel Dekker, New York, pp 455–466

    Google Scholar 

  3. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL et al (1994) Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 37:187–192

    Article  PubMed  CAS  Google Scholar 

  4. Ross R (1999) Atherosclerosis—an inflammatory disease. N Engl J Med 340:115–126

    Article  PubMed  CAS  Google Scholar 

  5. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486–2496

    Article  Google Scholar 

  6. Numano F (2000) Vasa vasoritis, vasculitis and atherosclerosis. Int J Cardiol 75(Suppl 1):S1–S8

    Article  PubMed  Google Scholar 

  7. Numano F, Kishi Y, Tanaka A, Ohkawara M, Kakuta T, Kobayashi Y (2000) Inflammation and atherosclerosis. Atherosclerotic lesions in Takayasu arteritis. Ann NY Acad Sci 902:65–76

    Article  PubMed  CAS  Google Scholar 

  8. Numano F, Okawara M, Inomata H, Kobayashi Y (2000) Takayasu's arteritis. Lancet 356:1023–1025

    Article  PubMed  CAS  Google Scholar 

  9. Filer A, Nicholls D, Corston R, Carey P, Bacon P (2001) Takayasu arteritis and atherosclerosis: illustrating the consequences of endothelial damage. J Rheumatol 28:2752–2753

    PubMed  CAS  Google Scholar 

  10. Sun Y, Yip PK, Jeng JS, Hwang BS, Lin WH (1996) Ultrasonographic study and long-term follow-up of Takayasu's arteritis. Stroke 27:2178–2182

    PubMed  CAS  Google Scholar 

  11. Sharma S, Sharma S, Taneja K, Gupta AK, Rajani M (1996) Morphologic mural changes in the aorta revealed by CT in patients with nonspecific aortoarteritis (Takayasu's arteritis). Am J Roentgenol 167:1321–1325

    CAS  Google Scholar 

  12. Taniguchi N, Itoh K, Honda M, Obayashi T, Nakamura M, Kawai F et al (1997) Comparative ultrasonographic and angiographic study of carotid arterial lesions in Takayasu's arteritis. Angiology 48:9–20

    Article  PubMed  CAS  Google Scholar 

  13. Lefebvre C, Rance A, Paul JF, Beguin C, Bletry O, Amoura Z et al (2000) The role of B-mode ultrasonography and electron beam computed tomography in evaluation of Takayasu's arteritis: a study of 43 patients. Semin Arthritis Rheum 30:25–32

    Article  PubMed  CAS  Google Scholar 

  14. Park SH, Chung JW, Lee JW, Han MH, Park JH (2001) Carotid artery involvement in Takayasu's arteritis: evaluation of the activity by ultrasonography. J Ultrasound Med 20:371–378

    PubMed  CAS  Google Scholar 

  15. Seyahi E, Ugurlu S, Cumali R, Balci H, Seyahi N, Yurdakul S, Yazici H (2006) Atherosclerosis in Takayasu arteritis. Ann Rheum Dis 65:1202–1207

    Article  PubMed  CAS  Google Scholar 

  16. Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM et al (1990) The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33:1129–1134

    Article  PubMed  CAS  Google Scholar 

  17. Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, Hoffman GS (1994) Takayasu arteritis. Ann Intern Med 120:919–929

    PubMed  CAS  Google Scholar 

  18. Bezerra MC, Calomeni GD, Caparbo VF, Gebrim ES, Rocha MS, Pereira RM (2005) Low bone density and low serum levels of soluble RANK ligand are associated with severe arterial calcification in patients with Takayasu arteritis. Rheumatol (Oxford) 44:1503–1506

    Article  CAS  Google Scholar 

  19. Siedel J, Hägele EO, Zielgenhorn J, Wahlefeld AW (1983) Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 29:1075–1080

    PubMed  CAS  Google Scholar 

  20. Fossati P, Prencipe L (1982) Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 28:2077–2080

    PubMed  CAS  Google Scholar 

  21. Warnick GR, Cheung NC, Albers JJ (1979) Comparison of current methods for high density lipoprotein cholesterol quantification. Clin Chem 25:596–604

    PubMed  CAS  Google Scholar 

  22. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502

    PubMed  CAS  Google Scholar 

  23. Williams CM (2004) Lipid metabolism in women. Proc Nutr Soc 63:153–160

    Article  PubMed  CAS  Google Scholar 

  24. Regitz-Zagrosek V, Lehmkuhl E, Mahmoodzadeh S (2007) Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease. Gend Med 4(Suppl B):S162–S177

    Article  PubMed  Google Scholar 

  25. Heiss G, Tamir I, Davis CE, Tyroler HA, Rifkand BM, Schonfeld G et al (1980) Lipoprotein-cholesterol distribution in selected North American populations: the lipid research clinics program prevalence study. Circulation 61:302–315

    PubMed  CAS  Google Scholar 

  26. Kannel WB, Hjortland MC, McNamara PM, Gordon T (1976) Menopause and risk of cardiovascular disease. The Framingham Study. Ann Intern Med 85:447–452

    PubMed  CAS  Google Scholar 

  27. Brown WV (1994) Lipoprotein disorders in diabetes mellitus. Med Clin North Am 78:143–161

    PubMed  CAS  Google Scholar 

  28. Thompson GR, Soutar AK, Spengel FA, Jadhav A, Gavigan SJ, Myant NB (1981) Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo. Proc Natl Acad Sci USA 78:2591–2595

    Article  PubMed  CAS  Google Scholar 

  29. Attman PO, Alaupovic P (1991) Lipid and apolipoprotein profiles of uremic dyslipoproteinemia—relation to renal function and dialysis. Nephron 57:401–410

    Article  PubMed  CAS  Google Scholar 

  30. Seko Y (2007) Giant cell and Takayasu arteritis. Curr Opin Rheumatol 19:39–43

    Article  PubMed  Google Scholar 

  31. Nashel DJ (1986) Is atherosclerosis a complication of long-term corticosteroid treatment. Am J Med 80:925–929

    Article  PubMed  CAS  Google Scholar 

  32. Al Rayyes O, Wallmark A, Florén CH (1997) Additive inhibitory effect of hydrocortisone and cyclosporine on low-density lipoprotein receptor activity in cultured HepG2 cells. Hepatology 26:967–971

    Article  PubMed  CAS  Google Scholar 

  33. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotto AM Jr (1998) Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 279:1615–1622

    Article  PubMed  CAS  Google Scholar 

  34. Park YB, Lee SK, Lee WK, Suh CH, Lee CW, Lee CH (1999) Lipid profiles in untreated patients with rheumatoid arthritis. J Rheumatol 26:1701–1704

    PubMed  CAS  Google Scholar 

  35. Borba EF, Bonfá E (1997) Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies. Lupus 6:533–539

    Article  PubMed  CAS  Google Scholar 

  36. de Carvalho JF, Borba EF, Viana VS, Bueno C, Leon EP, Bonfá E (2004) Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus? Arthritis Rheum 50:3610–3615

    Article  PubMed  CAS  Google Scholar 

  37. Quéméneur T, Martin-Nizard F, Kandoussi A et al (2007) PON1, a new biomarker of cardiovascular disease, is low in patients with systemic vasculitis. Semin Arthritis Rheum 37:149–155

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by grants of Conselho Nacional de Desenvolvimento Científico e Tecnológico [305691/2006-6 to R.M.R.P., 305468/2006-5 to E.B.] and Federico Foundation to E.B.

Disclosures

None

Author information

Authors and Affiliations

  1. Rheumatology Division, Faculdade de Medicina e Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil

    Jozélio Freire de Carvalho, Eloísa Bonfá, Mailze C. Bezerra & Rosa Maria Rodrigues Pereira

  2. Disciplina de Reumatologia, Faculdade de Medicina da Universidade de São Paulo, Av. Dr. Arnaldo 455, 3° andar, Sala 3105, São Paulo, SP, Brazil, 01246-903

    Rosa Maria Rodrigues Pereira

Authors
  1. Jozélio Freire de Carvalho
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eloísa Bonfá
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mailze C. Bezerra
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rosa Maria Rodrigues Pereira
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rosa Maria Rodrigues Pereira.

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Carvalho, J.F., Bonfá, E., Bezerra, M.C. et al. High frequency of lipoprotein risk levels for cardiovascular disease in Takayasu arteritis. Clin Rheumatol 28, 801–805 (2009). https://doi.org/10.1007/s10067-009-1153-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-009-1153-8

Keywords

Search

Navigation